|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 31806 |
FusionGeneSummary for RPL18_AR |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: RPL18_AR | Fusion gene ID: 31806 | Hgene | Tgene | Gene symbol | RPL18 | AR | Gene ID | 6141 | 374 |
| Gene name | ribosomal protein L18 | amphiregulin | |
| Synonyms | L18 | AR|AREGB|CRDGF|SDGF | |
| Cytomap | 19q13.33 | 4q13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 60S ribosomal protein L18large ribosomal subunit protein eL18 | amphiregulinamphiregulin Bcolorectum cell-derived growth factorschwannoma-derived growth factor | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q07020 | P10275 | |
| Ensembl transtripts involved in fusion gene | ENST00000549920, ENST00000550645, ENST00000552588, ENST00000549273, | ENST00000374690, ENST00000513847, ENST00000504326, ENST00000396044, ENST00000396043, | |
| Fusion gene scores | * DoF score | 20 X 12 X 6=1440 | 6 X 4 X 5=120 |
| # samples | 21 | 6 | |
| ** MAII score | log2(21/1440*10)=-2.77760757866355 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: RPL18 [Title/Abstract] AND AR [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | RPL18 | GO:0002181 | cytoplasmic translation | 25957688 |
| Tgene | AR | GO:0007173 | epidermal growth factor receptor signaling pathway | 12743035 |
| Tgene | AR | GO:0007186 | G-protein coupled receptor signaling pathway | 12743035 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | PRAD | TCGA-XQ-A8TA-01A | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000549920 | ENST00000374690 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000549920 | ENST00000513847 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000549920 | ENST00000504326 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000549920 | ENST00000396044 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000549920 | ENST00000396043 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000550645 | ENST00000374690 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000550645 | ENST00000513847 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000550645 | ENST00000504326 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000550645 | ENST00000396044 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000550645 | ENST00000396043 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000552588 | ENST00000374690 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000552588 | ENST00000513847 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000552588 | ENST00000504326 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000552588 | ENST00000396044 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| 5CDS-intron | ENST00000552588 | ENST00000396043 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| intron-intron | ENST00000549273 | ENST00000374690 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| intron-intron | ENST00000549273 | ENST00000513847 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| intron-intron | ENST00000549273 | ENST00000504326 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| intron-intron | ENST00000549273 | ENST00000396044 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
| intron-intron | ENST00000549273 | ENST00000396043 | RPL18 | chr19 | 49118588 | - | AR | chrX | 66914515 | + |
Top |
FusionProtFeatures for RPL18_AR |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| RPL18 | AR |
| Component of the large ribosomal subunit.{ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:25901680,ECO:0000269|PubMed:25957688, ECO:0000305|PubMed:12962325}. | Steroid hormone receptors are ligand-activatedtranscription factors that regulate eukaryotic gene expression andaffect cellular proliferation and differentiation in targettissues. Transcription factor activity is modulated by boundcoactivator and corepressor proteins. Transcription activation isdown-regulated by NR0B2. Activated, but not phosphorylated, byHIPK3 and ZIPK/DAPK3. {ECO:0000269|PubMed:14664718,ECO:0000269|PubMed:15563469, ECO:0000269|PubMed:17591767,ECO:0000269|PubMed:17911242, ECO:0000269|PubMed:18084323,ECO:0000269|PubMed:19345326, ECO:0000269|PubMed:20980437,ECO:0000269|PubMed:25091737}. Isoform 3 and isoform 4 lack the C-terminal ligand-binding domain and may therefore constitutively activate thetranscription of a specific set of genes independently of steroidhormones. {ECO:0000269|PubMed:19244107}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for RPL18_AR |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for RPL18_AR |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| RPL18 | FANCA, FANCC, ESR1, CD4, NOP56, DYRK2, ARRB2, CUL3, CUL4B, CUL5, CUL2, CDK2, CUL1, COPS5, COPS6, DCUN1D1, CAND1, RPL10A, RPL11, RPL12, RPL13, RPL15, RPL18A, RPL19, RPL21, RPL22, RPL23, RPL24, RPL27A, RPL31, RPL37A, RPL3, RPL4, RPL5, RPL6, RPL7A, RPL7, RPL8, RPL9, RPS13, RPS14, RPS15A, RPS16, RPS19, RPS23, RPS25, RPS26, RPS28, RPS2, RPS3A, RPS3, RPS4X, RPS5, RPS6, RPS7, RPS8, RPSA, RPL23A, RPL14, RPL30, RPS24, RPS12, RPS20, RPS11, RPLP0, RPL36, RPL27, RPS9, RPL10, RPL35, RPS17, RPL38, RPL17, RPL32, RPS21, RPS27A, EEF2, EEF1A1, FBL, ILF3, HNRNPU, NCL, SLC25A5, ILF2, MYBBP1A, EEF1D, NHP2L1, ACTA2, HNRNPM, U2AF2, RPS27L, ATP5A1, MYL12A, RPL10L, RPLP0P6, NOP2, PTGES3, RPS10P5, ATP5B, HIST1H2AD, NIFK, HSP90AA5P, RHOA, TUBA1B, MRPL12, MAGOH, EIF4A3, PA2G4, FN1, VCAM1, IL7R, UBL4A, ITGA4, PAN2, IGSF8, ICAM1, CDKN1A, FBXO6, EEF1E1, FAU, IARS, NUDT21, RPA3, RPA2, RPA1, ZBTB1, STAU1, CEP250, TP53, HUWE1, FUS, CUL7, OBSL1, CCDC8, EED, RBM4B, NTRK1, HNRNPUL2, PABPC1, PABPC4, RPL13A, RPL26L1, RPL3L, RPLP1, RPS27, RPL26, RPL34, RPL35A, RPLP2, RPS10, RPS15, RPS18, LOC101929876, SFN, XPO1, NPM1, CENPQ, SKI, MCM2, NF2, RC3H1, ZNF746, CEBPZ, PDCD11, FNTB, VPRBP, UBE2O, NOC2L, RRP8, CNBP, NLE1, NSUN4, KIAA0020, MINA, GNL2, RRS1, EBNA1BP2, CENPC, REXO4, TTC19, RBM34, NOL8, NAP1L1, GTPBP4, RBM28, ZC3H10, SPTY2D1, DKC1, DDX10, C1QBP, FTSJ3, MRPL48, DDX27, FNTA, MECP2, BRIX1, NAP1L4, ZNF512, MRPS31, DDX51, ZNF22, ZC3HAV1, DDX24, DDX52, MRPL16, RRP7A, MRPS33, MRPL28, ZNF644, HERC5, MRPS9, FCF1, MRPL13, MRPS18C, MRPL32, MRPS35, RBM19, DDX54, NOC3L, RPL28, MRPL47, URB1, DDX56, DHX30, RRP1, ZNF771, BUD13, RPF2, PAK1IP1, MRPL27, MRPL24, NSA2, DDX18, C3orf17, MRPL20, PPAN-P2RY11, MRPL17, MRPS5, MRPL3, UTP3, GNL3, MRPS10, MRPL51, CYLD, INO80B, TRIM25, BRCA1, YAP1 | AR | GNB2L1, FLNA, RAN, NR2C2, NCOA3, RNF4, NCOA4, PAK6, RANBP9, RCHY1, PIAS2, HNF4A, AKT1, IL6ST, CALM1, RAD9A, SMAD3, NCOA6, CTNNB1, CCNH, CDK7, AR, DAXX, STAT3, SP1, GSK3B, GSN, SELENBP1, HSPA1A, HSP90AA1, UXT, CAV1, JUN, PRKDC, XRCC5, XRCC6, BAG1, CREBBP, NCOA1, NCOR1, NCOR2, NCOA2, CCND1, FOXO1, FOXA1, RNF14, DCC, MAGEA11, SRC, PTEN, RB1, BRCA1, ZMIZ1, TP53, TGFB1I1, MAPK1, EGFR, GSK3A, KAT7, NR2C1, GRIP1, PELP1, SART3, HDAC3, HDAC4, TDG, PSPC1, NONO, EFCAB6, KAT5, HDAC1, CDK9, NSD1, YWHAQ, PRMT1, TSG101, COX5B, RAF1, NR0B2, POU2F1, POU2F2, DAP3, CEBPA, CEBPB, SVIL, AES, FHL2, CDC37, PIAS4, NR0B1, TMF1, SRY, CCNE1, UBE2I, SMAD4, CALR, SPDEF, PATZ1, ETV5, PA2G4, PIAS1, PIAS3, HMGB1, HMGB2, PRPF6, TRIM24, GTF2F1, GTF2F2, TBP, GTF2H1, MED1, GAPDH, CDC25B, PMEPA1, SMARCA4, SMARCC1, TRIM68, HSPB2, MDM2, WHSC1, MDN1, NLRP10, SMARCA2, ZBTB16, MED24, DENND5A, ZBTB1, MED12L, SMARCD1, SPOP, MLH3, KIFAP3, PHB, SIRT1, HDAC7, ZNF318, SMARCE1, RAD54L2, EP300, ZMIZ2, TGIF1, SREBF1, RUVBL1, KDM5B, SFPQ, GADD45GIP1, ERG, KDM4A, KDM4D, RREB1, SRCAP, TADA3, USP26, RNF6, NELFCD, STUB1, REPS2, KIF1A, RNF40, RNF20, ERCC3, ERCC2, GTF2H2, GTF2H3, CHD8, SETD7, ZBTB7A, E2F1, E2F4, PSMC3, LCOR, LATS2, ZNF451, COPS2, USP10, TAF1, TNK2, DDB2, PAX6, ARID5A, WDR77, TCF20, DCAF6, FKBP5, FKBP4, PPP5C, DNAJC7, PPID, ZBTB32, TAB2, TBL1XR1, SIN3A, SIN3B, PARK7, UBE3A, KDM3A, APPL1, SIAH2, ACTB, JMJD1C, SMAD1, VHL, CUL2, PTGES3, RBL1, USP12, SKP2, REL, WIPI1, NDE1, VCP, DAPK3, AATF, TTC5, KAT2B, IFI16, EZH2, SUZ12, EED, RNF2, BMI1, RELA, PRKG1, MID1, TCF7L2, ELF3, IDE, CDK6, ETS1, KLK3, USP7, HOTAIR, PPP1CA, AHR, WDR20, WDR48, PRPF8, PPP2CA, CACUL1, KDM1A, USP14, SMARCC2, TLE3, GSE1, ARID1A, ARID1B, BCOR, SMARCB1, KMT2D, CHD7, RCOR1, DPF1, RAI1, TFAP2A, PPP2R2A, DPF2, ARID3B, CNBP, ARID5B, NEFL, RPS21, SPATS2L, RCC2, DDX19A, KARS, SUV39H2, BRD4, BRD2, BRD3 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RPL18_AR |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | RPL18 | Q07020 | DB11638 | Artenimol | 60S ribosomal protein L18 | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB00421 | Spironolactone | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB00623 | Fluphenazine | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB00648 | Mitotane | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB00655 | Estrone | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB00675 | Tamoxifen | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB01063 | Acetophenazine | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB01128 | Bicalutamide | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB01395 | Drospirenone | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB01406 | Danazol | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB06710 | Methyltestosterone | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB08867 | Ulipristal | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB08899 | Enzalutamide | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB09123 | Dienogest | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB09371 | Norethynodrel | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB09389 | Norgestrel | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB11619 | Gestrinone | Androgen receptor | small molecule | approved |
| Tgene | AR | P10275 | DB01185 | Fluoxymesterone | Androgen receptor | small molecule | approved|illicit |
| Tgene | AR | P10275 | DB06412 | Oxymetholone | Androgen receptor | small molecule | approved|illicit |
| Tgene | AR | P10275 | DB00255 | Diethylstilbestrol | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB00367 | Levonorgestrel | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB00499 | Flutamide | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB00621 | Oxandrolone | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB00624 | Testosterone | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB00665 | Nilutamide | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB00687 | Fludrocortisone | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB00957 | Norgestimate | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB01026 | Ketoconazole | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB01608 | Propericiazine | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB04839 | Cyproterone acetate | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB06713 | Norelgestromin | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB08604 | Triclosan | Androgen receptor | small molecule | approved|investigational |
| Tgene | AR | P10275 | DB01708 | Prasterone | Androgen receptor | small molecule | approved|investigational|nutraceutical |
| Tgene | AR | P10275 | DB00396 | Progesterone | Androgen receptor | small molecule | approved|vet_approved |
Top |
RelatedDiseases for RPL18_AR |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | RPL18 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Tgene | AR | C0039585 | Androgen-Insensitivity Syndrome | 73 | CTD_human;ORPHANET;UNIPROT |
| Tgene | AR | C0268301 | Reifenstein Syndrome | 49 | ORPHANET;UNIPROT |
| Tgene | AR | C0033578 | Prostatic Neoplasms | 20 | CTD_human |
| Tgene | AR | C0011570 | Mental Depression | 5 | PSYGENET |
| Tgene | AR | C0011581 | Depressive disorder | 5 | PSYGENET |
| Tgene | AR | C0021364 | Male infertility | 3 | CTD_human |
| Tgene | AR | C0236663 | Alcohol withdrawal syndrome | 3 | PSYGENET |
| Tgene | AR | C0001973 | Alcoholic Intoxication, Chronic | 2 | PSYGENET |
| Tgene | AR | C0242788 | Breast Neoplasms, Male | 2 | CTD_human |
| Tgene | AR | C1458155 | Mammary Neoplasms | 2 | CTD_human |
| Tgene | AR | C3658267 | Prostatic Neoplasms, Castration-Resistant | 2 | CTD_human |
| Tgene | AR | C0002170 | Alopecia | 1 | CTD_human |
| Tgene | AR | C0004114 | Astrocytoma | 1 | CTD_human |
| Tgene | AR | C0004352 | Autistic Disorder | 1 | CTD_human |
| Tgene | AR | C0017412 | Genital Diseases, Male | 1 | CTD_human |
| Tgene | AR | C0020538 | Hypertensive disease | 1 | CTD_human |
| Tgene | AR | C0021361 | Female infertility | 1 | CTD_human |
| Tgene | AR | C0021655 | Insulin Resistance | 1 | CTD_human |
| Tgene | AR | C0023418 | leukemia | 1 | CTD_human |
| Tgene | AR | C0027643 | Neoplasm Recurrence, Local | 1 | CTD_human |
| Tgene | AR | C0036341 | Schizophrenia | 1 | PSYGENET |
| Tgene | AR | C0085207 | Gestational Diabetes | 1 | CTD_human |
| Tgene | AR | C0282612 | Prostatic Intraepithelial Neoplasias | 1 | CTD_human |
| Tgene | AR | C0525045 | Mood Disorders | 1 | PSYGENET |
| Tgene | AR | C0556385 | Craving for alcohol | 1 | PSYGENET |
| Tgene | AR | C2239176 | Liver carcinoma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|